Top compounds associated with response to CCDC184


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.1
mRNA RO-3306 GDSC1000 pan-cancer AAC -0.059 0.1
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.059 0.1
mRNA 5-FU CTRPv2 pan-cancer AAC -0.059 0.1
mRNA CAL-101 GDSC1000 pan-cancer AAC -0.053 0.1
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.1
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.057 0.1
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC -0.063 0.1
mRNA PD173074 GDSC1000 pan-cancer AAC 0.058 0.1
Download CSV